Cardiology Research Analysis
Q1 2026 in cardiology blended transformative device innovation, precision electrophysiology, and layered hypertension strategies with mechanistic immuno‑metabolic advances. Conduction‑system pacing outperformed biventricular CRT, while a first‑in‑class aldosterone synthase inhibitor (baxdrostat) delivered robust ambulatory BP reduction that complements scalable, community health worker–led hypertension care. Energy‑harvesting pacemakers and self‑powered magnetoelastic smart stents signaled a shi